Return
Bayesian networks for interpretable machine learning and optimization
DOI:10.1016/j.neucom.2021.01.138.png)
Abstract
En 中文
As artificial intelligence is being increasingly used for high-stakes applications, it is becoming more and more important that the models used be interpretable. Bayesian networks offer a paradigm for inter-pretable artificial intelligence that is based on probability theory. They provide a semantics that enables a compact, declarative representation of a joint probability distribution over the variables of a domain by leveraging the conditional independencies among them. The representation consists of a directed acyclic graph that encodes the conditional independencies among the variables and a set of parameters that encodes conditional distributions. This representation has provided a basis for the development of algo-rithms for probabilistic reasoning (inference) and for learning probability distributions from data. Bayesian networks are used for a wide range of tasks in machine learning, including clustering, super -vised classification, multi-dimensional supervised classification, anomaly detection, and temporal mod-eling. They also provide a basis for estimation of distribution algorithms, a class of evolutionary algorithms for heuristic optimization. We illustrate the use of Bayesian networks for interpretable machine learning and optimization by presenting applications in neuroscience, the industry, and bioin-formatics, covering a wide range of machine learning and optimization tasks. (c) 2021 Published by Elsevier B.V.
Keywords:
Interpretability
Explainable machine learning
Probabilistic graphical models
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
6.5
Papers:
2.5W
Citations:
6.5W
Organization
Cited Papers
A Directional-Linear Bayesian Network and Its Application for Clustering and Simulation of Neural Somas
IEEE ACCESS
IF3.6
Brain and other nervous system disorders across the lifespan - global challenges and opportunitiesINTRODUCTION
NATURE
IF48.5
IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery
RSC Advances
IF0

